目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T40392 | |||
BMS-986121, a positive allosteric modulator (PAM) of the μ opioid receptor. This compound is based on a novel chemical scaffold, introducing a new chemotype for μ receptor PAMs. | |||
T73903 | |||
UNC4976 TFA为CBX7染色质结构域与核酸结合的PAM(正变构调节剂)拟肽。通过拮抗H3K27me3,特异性阻断CBX7对靶基因的募集,同时促进了与DNA和RNA的非特异性结合。 | |||
T39545 | |||
MK-6884, a positive allosteric modulator (PAM) of M4 muscarinic receptors, exhibits a high affinity (Ki = 0.19 nM). It is a valuable compound for the investigation of neurodegenerative diseases. Additionally, MK-6884 can be efficiently radiolabeled with carbon-11, enabling its use as a PET imaging agent. | |||
T62756 | |||
LY487379是一种选择性的人类 mGluR2 阳性异生调节剂(PAM)。LY487379 可提高谷氨酸刺激的 [35 S] GTPγS 结合,作用于 mGlu2 受体 (EC50: 1.7 μM) 和 mGlu3 受体 (EC50>10 μM)。LY487379 在大鼠模型中促使认知的灵活性,并诱导行为抑制。LY487379 能够用于研究精神分裂症。 | |||
T73081 | |||
(S)-V-0219 是 V-0219 的对映异构体。V-0219 是一种口服有效的 GLP 受体 (GLP Receptor,GLP-1R) 的正变构调节剂 (PAM)。(S)-V-0219 可激活表达 hGLP-1R 的 HEK 细胞中的钙流。(S)-V-0219 具有口服活性,可改善小鼠体内的高葡萄糖水平,并抑制禁食小鼠的进食行为。 | |||
T27855 | |||
LSN2814617 是一种口服有效的、能透过血脑屏障的和选择性的mGlu5(代谢性谷氨酸 5) 正向别构调节剂 (PAM),其EC50值为 52 nM (Human mGlu5) 和 42 nM (rat mGlu5)。体内EGG 研究表明,LSN2814617 具有显著的促醒作用,并且几乎不会反弹过度嗜睡,可用于精神分裂症研究。 | |||
T35080 | |||
VU0456940 is a potent M1 PAM with excellent selectivity (hM1 EC50 = 340 nM, 14-fold leftward shift of the ACh CRC; hM2–hM5 inactive). VU0456940 potentiated the excitation of a subthreshold concentration of CCh in MSNs. VU0456940 shifted APP processing and | |||
T74265 | |||
(S)-V-0219 hydrochloride 是 V-0219 的对映异构体。V-0219 是一种口服有效的 GLP 受体 (GLP Receptor,GLP-1R) 的正变构调节剂 (PAM)。(S)-V-0219 hydrochloride 可激活表达 hGLP-1R 的 HEK 细胞中的钙流。(S)-V-0219 hydrochloride 具有口服活性,可改善小鼠体内的高葡萄糖水平,并抑制禁食小鼠的进食行为。 | |||
T39771 | |||
nAChR agonist CMPI hydrochloride is a potent and selective positive allosteric modulator (PAM) of nAChR containing a α4:α4 subunit interface. nAChR agonist CMPI hydrochloride enhances the response of (α4) 3 (β2) 2 nAChR to ACh (10 μM) with an EC 50 of 0.26 μM. nAChR agonist CMPI hydrochloride has potential for the research of nicotine dependence and many neuropsychiatric conditions associated with decreased brain cholinergic activity. | |||
T78971 | iGluR | ||
AMPA receptor modulator-4 是一种口服有效的 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide (BTD) 类 AMPA 受体正变构调节剂 (AMPAR PAM)。该化合物能穿透血脑屏障,能够增强小鼠的认知能力并改善其工作记忆。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-00392 | PAM Protein, Human, Recombinant (His) | Human | HEK293 Cells | ||
PAM Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 94.4 kDa and the accession number is P19021-2.
|
|||||
TMPY-01035 | JAM-A Protein, Human, Recombinant (His) | Human | HEK293 Cells | ||
JAM-A Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 25 kDa and the accession number is Q9Y624-1.
|
|||||
TMPY-00865 | JAM-A Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
JAM-A Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 50 kDa and the accession number is Q9BQB4-1.
|
|||||
TMPY-00149 | PAM Protein, Human, Recombinant (hFc) | Human | HEK293 Cells | ||
PAM Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 104 kDa and the accession number is P19021-2.
|
|||||
TMPK-00188 | JAM-A Protein, Mouse, Recombinant (His) | Mouse | HEK293 Cells | ||
junctional adhesion molecule A (JAM-A), a cell adhesion molecule, is highly elevated in human GBM cancer stem cells and predicts poor patient prognosis. While JAM-A is also highly expressed in other cells in the tumor microenvironment, specifically microglia and macrophages,JAM-A functions to suppress pathogenic microglial activation in the female tumor microenvironment, highlighting an emerging role for sex differences in the GBM microenvironment and suggesting that sex differences extend beyond previously reported tumor cell-intrinsic differences.
|
|||||
TMPJ-00965 | TIM16 Protein, S. cerevisiae, Recombinant | S. cerevisiae | E. coli | ||
Mitochondrial import inner membrane translocase subunit TIM16 (TIM16) is an ssential component of the PAM complex. PAM complex is required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. In the complex, TIM16 is required to regulate activity of mtHSP70 (SSC1) via its interaction with PAM18/TIM14. TIM16 may act by positioning PAM18/TIM14 in juxtaposition to mtHSP70 at the translocon to maximize ATPase stimulation.
|
|||||
TMPJ-01087 | TIM14 Protein, S. cerevisiae, Recombinant | S. cerevisiae | E. coli | ||
Mitochondrial import inner membrane translocase subunit TIM14 (TIM14) is an essential component of the PAM complex. PAM complex is required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. In the complex, TIM14 is required to stimulate activity of mtHSP70 (SSC1). TIM14 belongs to the DnaJ family, which has been involved in Hsp40/Hsp70 chaperone systems. As a mitochondrial chaperone, TIM14 functions as part of the TIM23 complex import motor to facilitate the import of nuclear-encoded proteins into the mitochondria. TIM14 also complexes with prohibitin complexes to regulate mitochondrial morphogenesis, and has been implicated in dilated cardiomyopathy with ataxia.
|
|||||
TMPH-01690 | TIM14 Protein, Human, Recombinant (GST) | Human | E. coli | ||
Mitochondrial co-chaperone which forms a complex with prohibitins to regulate cardiolipin remodeling. May be a component of the PAM complex, a complex required for the translocation of transit peptide-containing proteins from the inner membrane into the mitochondrial matrix in an ATP-dependent manner. May act as a co-chaperone that stimulate the ATP-dependent activity.
|